Neurology News

History of stroke was associated with increased odds of cognitive impairment in both non-Hispanic white and Mexican American individuals, researchers reported.

Implantable loop recorder screening for atrial fibrillation did not significantly reduce the risk for stroke compared with usual care, according to study results published in JAMA Neurology.

Following a hybrid conference last year, PAINWeek 2022 will be back in full swing, as this year’s meeting will be fully in-person.

The 2022 PAINWeek and BRAINWeek conferences, Sept. 6-9 and Sept. 28-30 in Las Vegas, will feature migraine tracks presented by the world-renowned Diamond Headache Clinic.

The American Society of Interventional Pain Physicians and the Interventional Pain Management Tracks will return to the PAINWeek National Conference, taking place Sept. 6-9 in Las Vegas.

Amneal Pharmaceuticals Inc. announced it has submitted a new drug application to the FDA for IPX203, an oral formulation of carbidopa/levodopa extended-release capsules for the treatment of Parkinson’s disease.

This year’s PAINWeek conference, Sept. 6-9 in Las Vegas, will feature more than 75 credit hours of pain management tracks, including the Advanced Practice Provider Track, featuring diverse faculty with expertise in pain management.

If you are a physician who follows the financial media, amid the stories of gloom and doom, you have likely heard of a new investment strategy being offered by many financial institutions called direct indexing.

In this edition, BMI is associated with dementia in women and linked with disease in men; Healthy diet, physical activity are linked to lower mortality in adults with PD; mild TBI and CT scans and more.

Rafa Laboratories announced the FDA has granted approval for its 10 mg midazolam autoinjector to treat status epilepticus in adults.